SecondWave Systems, Inc., a St. Paul, MN-based clinical stage medical device company, raised $7M Series A funding.
The round was led by Treo Ventures and a major healthcare strategic, with participation from Scientific Health Development and the University of Minnesota’s Discovery Capital and SSBCI funds.
The company intends to support its next clinical study, leveraging the success of their first-in-human study that demonstrated a reduction in rheumatoid arthritis disease activity.
Led by CEO Anuj Bhardwaj, SecondWave Systems develops treatments for inflammatory disease. The company is developing a noninvasive, wearable, and personalized ultrasound stimulation platform that will give patients and their physicians a new option for treating debilitating or life-threatening disease. It’s SecondWave MINI™ device uses proprietary low-intensity focused ultrasound technology to stimulate the spleen with the goal of treating acute and chronic inflammation disorders.
FinSMEs
08/04/2025